LOS ANGELES CAPITAL MANAGEMENT LLC

Position in NKTX — Nkarta, Inc.

CIK 1177206 LOS ANGELES, CA

Position in NKTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$115,656

-$28,467 QoQ

Shares Held

40,868

-40.2% QoQ

Ownership

0.057%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#67

of 136 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. NKTX ranks #100 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	729,635	$219,642,024
2	HALO	Halozyme Therapeutics, Inc.	1,938,035	$151,689,999
3	CAI	Caris Life Sciences, Inc.	3,958,531	$70,541,022
4	INCY	Incyte Corp	578,986	$65,633,852
5	VRTX	Vertex Pharmaceuticals Inc / Ma	130,802	$64,973,277
6	EXEL	Exelixis, Inc.	1,159,457	$63,086,055
7	REGN	Regeneron Pharmaceuticals, Inc.	98,585	$61,471,690
8	RPRX	Royalty Pharma plc	877,674	$49,211,181

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$115,656	40,868	-40.2%	Shares	Sole	2026-08-13
2026-03-31	$144,123	68,305	-52.2%	Shares	Sole	2026-05-08
2025-12-31	$264,244	142,835	-0.3%	Shares	Sole	2026-02-11
2025-09-30	$296,616	143,293	-4.2%	Shares	Sole	2025-10-20
2025-06-30	$248,219	149,530	+81.8%	Shares	Sole	2025-08-07
2025-03-31	$151,321	82,240	+30.8%	Shares	Sole	2025-05-05
2022-03-31	$715,471	62,871	+446.2%	Shares	Sole	2022-05-06
2021-12-31	$176,693	11,511	-1.2%	Shares	Sole	2022-02-03
2021-09-30	$324,042	11,652	0.0%	Shares	Sole	2021-11-08
2021-06-30	$369,251	11,652	—	Shares	Sole	2021-08-05
No filing history on record for this holder in this stock.